...
首页> 外文期刊>DMW: Deutsche Medizinische Wochenschrift >No opiates against cannabis hyperemesis syndrome [Keine Opiate gegen das Cannabis-Hyperemesis-Syndrom]
【24h】

No opiates against cannabis hyperemesis syndrome [Keine Opiate gegen das Cannabis-Hyperemesis-Syndrom]

机译:没有针对大麻呕吐综合征的鸦片制剂[没有针对大麻呕吐综合征的鸦片制剂]

获取原文
获取原文并翻译 | 示例
           

摘要

History and clinical findings: An otherwise healthy 25-year-old patient with heavy cannabis-abuse suffered from an undiagnosed cannabis hyperemesis syndrome (CHS) over years, which characteristically was resistant to usual antiemetics. In an apparently last attempt at healing, opiates (morphine, methadone) were administrated and improved the CHS, however, this led to an at least as equally distressing and painful opiate withdrawal syndrome. Treatment and course: In the controlled cannabis abstinence during the 2-week inpatient treatment of opiate addiction syndrome the CHS has not recurred. Conclusion: Opiates are not suited for the treatment of CHS because they are addictive and lead to respiratory depression in overdose.
机译:病史和临床发现:一名健康的25岁重度滥用大麻的患者,多年来一直遭受未确诊的大麻呕吐综合征(CHS)的困扰,其特征是对常规止吐药有抵抗力。在显然的最后一次康复尝试中,服用了鸦片(吗啡,美沙酮)并改善了中枢神经系统,但是,这至少导致了同样令人痛苦的阿片戒断综合症。治疗和过程:在2周的阿片成瘾综合症住院治疗期间,在控制性大麻禁忌中,CHS尚未复发。结论:阿片类药物不适合中枢神经系统治疗,因为它们会上瘾并且服用过量会导致呼吸抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号